DiaSorin SpA (DIA):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:DiaSorin SpA (DIA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7083
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DiaSorin S.p.A. (DiaSorin) is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry (RIA), Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techniques, to enable automatic diagnostic investigation. The company’s products find application in the diagnosis of infectious diseases, bone and mineral disorders, endocrinology, hypertension, oncology, gastrointestinal infections, autoimmune disorders, and neurological and cardiac diseases. DiaSorin markets its products through direct sales force and distributors. It has operations in North America, South America, South Africa, EMEA and Asia. DiaSorin is headquartered at Saluggia, Piemonte, Italy.

DiaSorin SpA (DIA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
DiaSorin SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
DiaSorin SpA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
DiaSorin SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
DiaSorin SpA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
DiaSorin SpA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
DiaSorin SpA, Medical Equipment, Deal Details 10
Asset Purchase 10
DiaSorin Acquires ELISA Immunodiagnostic Business Portfolio from Siemens Healthcare for USD55.3 Million 10
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 11
Biotrin International Acquires Molecular Diagnostic Business Of NorDiag For US$10 Million 13
Partnerships 14
Evogen Enters Into Licensing Agreement With Focus Diagnostics For HyBeacons PCR Probe Technology 14
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 15
DiaSorin Enters into Agreement with Tecan 16
DiaSorin Enters into Agreement with QIAGEN 17
DiaSorin Enters into Agreement with Beckman Coulter 18
DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics 19
Enzo Clinical Enters Into Collaboration Agreement With DiaSorin 20
DiaSorin Forms Joint Venture With Trivitron Healthcare 21
Asset Transactions 22
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 22
DiaSorin SpA – Key Competitors 24
DiaSorin SpA – Key Employees 25
DiaSorin SpA – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Financial Announcements 28
Aug 02, 2018: The Board of Directors approves the results for the first half of 2018 28
May 08, 2018: The Diasorin Group Reports Growth in Revenues and Profitability in the First Quarter 2018 32
Nov 09, 2017: Growth In Revenues And Net Profit In Q3 2017. Strong Free Cash Flow Generation. 2017 Guidance Confirmed 35
Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017 36
May 08, 2017: Diasorin Group Reports Growth In Revenues And Profitability In The First Quarter 2017, Generating A Relevant Free Cash Flow 39
Mar 08, 2017: Net Profit And Cash Generation Reached Record Highs In 2016, Driven By Growth In Revenues And Profitability 41
Product News 44
Jun 12, 2018: Diasorin Introduces Primer Pair Reagents For Use In Molecular Testing: Anaplasma Phagocytophilum, Ehrlichia And Babesia 44
Jun 12, 2018: DiaSorin Molecular Introduces Primer Pair Reagents for A. phagocytophilum, Ehrlichia and Babesia 45
Sep 26, 2017: DiaSorin Molecular Introduces Two Primer Pair Reagents for Streptococcus 46
Jul 28, 2017: Diasorin Launches 3 New Primer Pairs For Use In Molecular Testing: Pneumocystis Jirovecii, Group C Streptococcus, And Group G Streptococcus 47
Other Significant Developments 48
Jun 26, 2017: Diasorin Presents Its 2017-2019 Industrial Plan 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
DiaSorin SpA, Medical Equipment, Key Facts, 2017 2
DiaSorin SpA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
DiaSorin SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
DiaSorin SpA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
DiaSorin SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
DiaSorin SpA, Deals By Market, 2012 to YTD 2018 8
DiaSorin SpA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
DiaSorin Acquires ELISA Immunodiagnostic Business Portfolio from Siemens Healthcare for USD55.3 Million 10
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 11
Biotrin International Acquires Molecular Diagnostic Business Of NorDiag For US$10 Million 13
Evogen Enters Into Licensing Agreement With Focus Diagnostics For HyBeacons PCR Probe Technology 14
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 15
DiaSorin Enters into Agreement with Tecan 16
DiaSorin Enters into Agreement with QIAGEN 17
DiaSorin Enters into Agreement with Beckman Coulter 18
DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics 19
Enzo Clinical Enters Into Collaboration Agreement With DiaSorin 20
DiaSorin Forms Joint Venture With Trivitron Healthcare 21
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 22
DiaSorin SpA, Key Competitors 24
DiaSorin SpA, Key Employees 25
DiaSorin SpA, Other Locations 26
DiaSorin SpA, Subsidiaries 26

List of Figures
DiaSorin SpA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
DiaSorin SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
DiaSorin SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
DiaSorin SpA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
DiaSorin SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
DiaSorin SpA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
DiaSorin SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
DiaSorin SpA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[DiaSorin SpA (DIA):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nuance Communications Inc (NUAN):企業の財務・戦略的SWOT分析
    Nuance Communications Inc (NUAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Elizabeth Arden, Inc.:企業の戦略的SWOT分析
    Elizabeth Arden, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Harbin Gloria Pharmaceuticals Co Ltd (002437):製薬・医療:M&Aディール及び事業提携情報
    Summary Harbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produces and markets nutritional drugs. The company’s products include pharmaceutical drugs for treating nutrition disorders, cancer, cardiovascular diseases, antitumor medication, respiratory medication, a …
  • Trevena Inc (TRVN):企業の財務・戦略的SWOT分析
    Summary Trevena Inc (Trevena) is a biotechnology company that discovers and develops G-protein coupled receptor targeted medicines. The company provides products such as RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination w …
  • Oxford BioMedica Plc (OXB):製薬・医療:M&Aディール及び事業提携情報
    Summary Oxford BioMedica plc (Oxford Biomedica) is a gene and cell therapy company that focuses on developing novel treatments for serious diseases. The company along with its subsidiaries has developed LentiVector, a sector leading lentiviral vector delivery platform. It has also built a platform o …
  • Aggreko Plc (AGK):企業の財務・戦略的SWOT分析
    Aggreko Plc (AGK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Connecticut Municipal Electric Energy Cooperative:企業の戦略的SWOT分析
    Connecticut Municipal Electric Energy Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competi …
  • Invenra Inc-製薬・医療分野:企業M&A・提携分析
    Summary Invenra Inc (Invenra) is a healthcare services provider that offers therapeutic solutions. The company discovers therapeutic human antibodies and their derivatives. It uses its proprietary technology to combine the ribosome display, cell free expression of antibodies with miniaturization, mi …
  • Innospec Inc. (IOSP):石油・ガス:M&Aディール及び事業提携情報
    Summary Innospec Inc (Innospec) is a provider of specialty chemicals. It blends, manufactures and supplies fuel additives and other specialty chemicals. Innospec’s product portfolio includes stabilizers, detergents, cold flow improvers, lubricity improvers, corrosion inhibitors, conductivity improve …
  • Dignity plc (DTY):企業の財務・戦略的SWOT分析
    Dignity plc (DTY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • SK Hynix Inc.:企業の戦略・SWOT・財務情報
    SK Hynix Inc. - Strategy, SWOT and Corporate Finance Report Summary SK Hynix Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Societatea Nationala Nuclearelectrica SA (SNN):企業の財務・戦略的SWOT分析
    Societatea Nationala Nuclearelectrica SA (SNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Shuwen Biotech Co Ltd:企業の製品パイプライン分析2018
    Summary Shuwen Biotech Co Ltd (Shuwen Biotech) is a medical equipment company. The company develops diagnostic products and services for disease prevention, diagnosis and personalized medicine. It offers in-vitro diagnostic (IVD) kits for oncology and pregnancy-related conditions. Shuwen Biotech dev …
  • Informa plc:企業の戦略・SWOT・財務情報
    Informa plc - Strategy, SWOT and Corporate Finance Report Summary Informa plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Bonheur ASA (BON):企業の財務・戦略的SWOT分析
    Summary Bonheur ASA (Bonheur) is an oil and gas investment service provider that offers investment services for various energy sectors. The company invests in renewable energy, cruise, shipping and offshore wind, offshore drilling, and other investments. It operates shipping vessels for transport an …
  • Generali Brasil Seguros S.A.:企業の戦略・SWOT・財務情報
    Generali Brasil Seguros S.A. - Strategy, SWOT and Corporate Finance Report Summary Generali Brasil Seguros S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Shree Rama Newsprint Limited (RAMANEWS):企業の財務・戦略的SWOT分析
    Shree Rama Newsprint Limited (RAMANEWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Athena Investments AS (ATHENA):企業の財務・戦略的SWOT分析
    Athena Investments AS (ATHENA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • ALK-Abello AS (ALK B):製薬・医療:M&Aディール及び事業提携情報
    Summary ALK-Abello AS (ALK), a subsidiary of The Lundbeck Foundation discovers, develops and commercializes immunotherapies for allergy prevention and treatment. It markets diagnostics and other services to allergy clinics. The company's allergy immunotherapy product portfolio includes tablet-based …
  • Supernus Pharmaceuticals Inc (SUPN):企業の財務・戦略的SWOT分析
    Supernus Pharmaceuticals Inc (SUPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆